The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by ...
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...
The Biden administration has proposed a plan for Medicare and Medicaid to offer coverage for weight loss medications, such as ...
This may be the first Thanksgiving for millions of Americans who are on GLP-1 agonists like Ozempic, Zepbound or Wegovy.
The Biden administration plans to require Medicare and Medicaid to offer coverage of weight loss medications for patients ...
Medicare and Medicaid would be required to cover weight loss drug prescriptions for millions of obese Americans under plans ...
The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...